Open AccessBromelain and cardiovascular risk factors in diabetes: An exploratory randomized, placebo controlled, double blind clinical trial
Author(s) -
Chit Moy Ley,
Qing Ni,
Xing Liao,
Huailin Gao,
Nicola Robinson
Publication year - 2016
Publication title -
chinese journal of integrative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.464
H-Index - 34
eISSN - 1993-0402
pISSN - 1672-0415
DOI - 10.1007/s11655-016-2521-2
Subject(s) - placebo , medicine , fibrinogen , bromelain , randomized controlled trial , placebo controlled study , diabetes mellitus , gastroenterology , surgery , double blind , endocrinology , pathology , chemistry , biochemistry , alternative medicine , protease , enzyme
To assess whether the dietary supplement (bromelain) has the potential to reduce plasma fibrinogen and other cardiovascular disease (CVD) risk factors in patients with diabetes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom